The Valley Desk

NCT00272987 · Interventional trial

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Overall registry status Terminated

Phase 3

Conditions Neoplasms, Breast

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov